Stock Events

Stock Events

Aclaris Therapeutics (8AT.F) Q2 2024 Earnings

7MayConfirmed

Q2 2023

Q3 2023

Q4 2023

Q2 2024

-0.27

-0.25

-0.24

-0.22

Details

Expected EPS

-0.26571402000000005

Actual EPS

-0.2232

Surprise EPS

0.04

Surprise Percent

+16%

Description

Aclaris Therapeutics (8AT.F) has reported earnings of -0.2232 per share for Q2 2024.

0 Comments

Share your thoughts

Get the Stock Events App

Sign up for a Stock Events account to create your own watchlists and track your portfolio or dividends.